PerkinElmer, Inc. Launches First Fully Automated Genetic Disorder Screening System In China

WALTHAM, Mass. & SHANGHAI--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has received market authorization from the China Food and Drug Administration (CFDA) to offer its Genetic Screening Processor® (GSP) instrument and GSP Neonatal hTSH reagent kit.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC